These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34934470)

  • 1. Expert consensus on the use of omalizumab in chronic urticaria in China.
    Zhao Z; Cai T; Chen H; Chen L; Chen Y; Gao X; Gao X; Geng S; Guo Y; Hao F; Hao G; Hu Y; Jin H; Jin Z; Li C; Li H; Li J; Li Y; Liang Y; Liu G; Liu Q; Long H; Ma L; Shang Y; Song Y; Song Z; Su X; Sui H; Sun Q; Sun Y; Tang J; Tong X; Wang H; Wang G; Wang L; Wang S; Xiang L; Xiao T; Xie Z; Ye L; Yu Y; Zhang C; Zhang L; Zhang S; Zheng R; Zhi L; Zhou W; Zou Y; Maurer M
    World Allergy Organ J; 2021 Nov; 14(11):100610. PubMed ID: 34934470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
    Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
    World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
    Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
    J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
    Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
    World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
    ; Yu R; Qian W; Zheng Q; Xiong J; Chen S; Chen A; Chen J; Fang S; Huang K; Cai T
    Int Arch Allergy Immunol; 2023; 184(7):643-655. PubMed ID: 36996780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.
    He ZH; Qiu SC; Huang ZW; Zhang GQ; An QQ; Qu F; Wang N
    Dermatol Ther; 2022 Dec; 35(12):e15928. PubMed ID: 36222320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
    Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
    World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria.
    Ornek Ozdemir S; Can PK; Degirmentepe EN; Kızıltaç K; Singer R; Kocatürk E
    Int Arch Allergy Immunol; 2024; 185(11):1055-1065. PubMed ID: 38889696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
    Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria.
    Sarti L; Barni S; Giovannini M; Liccioli G; Novembre E; Mori F
    Pediatr Allergy Immunol; 2021 Jan; 32(1):153-160. PubMed ID: 32745323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
    Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
    Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.
    Marcelino J; Costa AC; Mendes A; Alonso E; Cabral Duarte F; Pedro E; Pereira-Barbosa M
    Eur Ann Allergy Clin Immunol; 2018 Jul; 50(4):169-176. PubMed ID: 29479938
    [No Abstract]   [Full Text] [Related]  

  • 16. The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.
    Maurer M; Zuberbier T; Metz M
    Handb Exp Pharmacol; 2022; 268():117-133. PubMed ID: 34247278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements.
    Giménez-Arnau A; Ferrer M; Bartra J; Jáuregui I; Labrador-Horrillo M; Frutos JO; Silvestre JF; Sastre J; Velasco M; Valero A
    Allergol Immunopathol (Madr); 2017; 45(2):134-144. PubMed ID: 28029407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.
    García-Gómez E; Chapman E; García-Paba MB; Ocampo-Gómez J; Egea-Bermejo E; Garavito-De Egea G; Fang L; Sarrazola M; Sánchez-Caraballo JM; Serrano-Reyes C; Silva-Espinosa DL; Rojas-Mejía DV; Moreno SM
    Front Allergy; 2022; 3():902344. PubMed ID: 35769574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Urticaria: An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Ng WGG; Loo SK
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):27-37. PubMed ID: 30924425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Omalizumab in Elderly Patients with Chronic Urticaria: Is It a Safe Therapy?
    Narváez-Fernández EJ; Entrala A; Nin-Valencia A; Mir-Ihara P; Losantos-García I; Domínguez-Ortega J; González-Fernández MÁ; Quirce S; Hernández-Cano N; Cabañas R; Caballero T
    Int Arch Allergy Immunol; 2023; 184(10):1003-1009. PubMed ID: 37231812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.